RAPT Therapeutics
Price & Volume
Stats
See more52W Range | $1-$27.35 |
Market Cap | $39.1M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $1.5M |
Diluted EPS | -$2.78 |
News
See moreYahoo Finance • 2 months ago
RAPT Therapeutics, Inc. (RAPT): Worst 52-Week Low Stock to Buy Now
Yahoo Finance • 2 months ago
RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability
Yahoo Finance • 12 months ago
RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Treat Atopic Dermatitis in Allergy
Yahoo Finance • last year
RAPT Therapeutics Reports Third Quarter 2023 Financial Results
About
CEO | Dr. Brian Russell Wong M.D., Ph.D. |
CFO | Mr. Rodney K. B. Young |
Address | 561 Eccles Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
